Clinical Trial

Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 3, 2025 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
A Phase 2a, Multicenter, Randomized, Open-label, Active Drug-controlled Trial to Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-27.
Status change: Not Yet Recruiting → Recruiting 2025-01-31
Trial Details
NCT Number NCT06664125
Lead Sponsor Jemincare
Conditions Hyperphosphatemia
Enrollment 50 participants
Start Date 2024-12-30
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-03